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Abstract
Cytokeratins (CK) are intermediate filaments whose
expression is often altered in epithelial cancer.
Systematic identification of lung adenocarcinoma
proteins using two-dimensional polyacrylamide gel
electrophoresis and mass spectrometry has uncov-
ered numerous CK isoforms. In this study, 93 lung
adenocarcinomas (64 stage I and 29 stage III ) and 10
uninvolved lung samples were quantitatively examined
for protein expression. Fourteen of 21 isoforms of CK
7, 8, 18, and 19 occurred at significantly higher levels
(P<.05) in tumors compared to uninvolved adjacent
tissue. Specific isoforms of the four types of CK
identified correlated with either clinical outcome or
individual clinical–pathological parameters. All five of
the CK7 isoforms associated with patient survival
represented cleavage products. Two of five CK7
isoforms (nos. 2165 and 2091), one of eight CK8
isoforms (no. 439), and one of three CK19 isoforms
(no. 1955) were associated with survival and signifi-
cantly correlated to their mRNA levels, suggesting that
transcription underlies overexpression of these CK
isoforms. Our data indicate substantial heterogeneity
among CK in lung adenocarcinomas resulting from
posttranslational modifications, some of which corre-
lated with patient survival and other clinical parame-
ters. Therefore, specific isoforms of individual CK may
have utility as diagnostic or predictive markers in lung
adenocarcinomas.
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Introduction
Lung cancer is the leading cause of cancer mortality among
men and women in the US, accounting for 158,900 deaths in
1999 [1]. An increase in the percentage of adenocarcinomas
has been recently observed, making adenocarcinomas the
most common histologic type of non small cell lung cancer. In
contrast to patients with advanced stages of lung adenocar-
cinomas, those presenting with stage I disease have overall
5-year survival rates of 55% to 63% [2]. Biomarkers that
serve to correctly stratify patients according to risk or to serve
as an early detection system may impact survival or help
direct therapy. To correctly identify these high- risk patients,
identification of biomarkers determined using genomic or
proteomic technologies may have great utility.
The cytokeratins (CK) belong to a large family of inter-
mediate filaments that are primarily expressed in epithelial
cells and whose members are expressed in various combi-
nations in both normal and neoplastic epithelium (reviewed in
Moll et al. [3 ] ). They are abundant proteins involved in the
structural organization of cells and the specific forms CK7,
CK8, CK18, and CK19 have been reported in lung adeno-
carcinomas [4–7] and in other cancer types [8,9]. These
proteins are often highly expressed by lung tumors and also
specifically modified with proteolytically altered forms
detected in the serum of lung cancer patients [7,8]. Little is
understood, however, regarding the expression of the
individual isoforms of these proteins or their relationship to
specific clinical or pathological features of these tumors.
In the present study, we utilized two-dimensional poly-
acrylamide gel electrophoresis (2D PAGE) and mass spec-
trometry (MS) to examine CK expression profiles of 93 lung
adenocarcinomas and 10 uninvolved lung samples. We have
examined within this cohort of lung adenocarcinomas both
early stage I and more aggressive stage III tumors to help
identify specific CK isoforms that are associated with poor
clinical outcome. Correlation between protein levels of the CK
isoforms and the CK gene mRNA expression was examined
to help delineate potential mechanisms underlying over-
expression of these proteins in lung tumors.
Materials and Methods
Sample Acquisition and Preparation
Sequential patients seen between May 1991 and July
2000 by the General Thoracic Surgery at the University of
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Michigan Hospital for resection of stages I and III lung
adenocarcinoma were evaluated for inclusion in this study.
Consent was received from all patients and the project
approved by the Institutional Review Board. Patient medical
records were reviewed and patient identifiers coded to
protect confidentiality. Tumor tissues and adjacent non-
neoplastic lung tissues were acquired immediately after
resection and carried to the laboratory in Dulbecco’s
modified Eagle’s medium (Life Technologies, Gaithersburg,
PA) on ice. This included 64 stage I, 29 stage III lung ade-
nocarcinomas, as well as 10 non-neoplastic lung samples
(Table 1). A portion of each tumor and/or lung tissue was
embedded in OCT (Miles Scientific, Naperville, IL), frozen in
isopentane cooled with liquid nitrogen for cryostat sectioning,
and then stored at 808C. Hematoxylin- and eosin-stained
cryostat sections (5 m), prepared from tumor pieces to be
utilized for mRNA isolation, were evaluated by a study
pathologist, and compared to H&E sections made from
paraffin blocks of the same tumor. Specimens were excluded
based on unclear ormixed histology (e.g., adenosquamous),
tumor cellularity less than 70%, potential metastatic origin as
indicated by previous tumor history, extensive lymphocytic
infiltration, extensive fibrosis, prior chemotherapy, or radio-
therapy. Tumors were histopathologically divided into two
categories: bronchial -derived, if they exhibited invasive
features with architectural destruction, and bronchioloalveo-
lar, if they exhibited preservation of the lung architecture.
The WHO classification of lung adenocarcinomas
includes acinar, papillary, bronchioloalveolar, and solid,
indicating the large heterogeneity recognized within these
tumors and there is also an overlap that exists between
WHO-recognized classes [10]. Because the bronchioloal-
veolar carcinomas have distinctive clinicopathologic fea-
tures, it is justifiable to separate them. We separated the
tumors into two broad histopathological classifications,
bronchial -derived and bronchioloalveolar. H&E–stained
paraffin sections were utilized to examine lymphocytic
response of tumors. Those demonstrating lymphocytic
accumulation either within or surrounding the tumors were
classified as having a positive lymphocytic response.
Tumors showing only mild or no lymphocytes were deemed
negative and those with moderate or extensive lymphocytes
were deemed positive.
2D PAGE
Protein samples were solubilized in standard lysis buffer
(9.5 M urea, 20 l of nonionic detergent [Nonidet P-40],
20 l of ampholines [pH 3.5–10; Pharmacia/LKB, Piscat-
away, NJ], 20 l of 2-mercaptoethanol, and 0.89 M
phenylmethylsulfonyl fluoride per milliliter of deionized
water ). Sample volumes of between 15 and 30 l were
immediately applied to isoelectric focusing gels containing
50 l of ampholytes per milliliter (pH 3.5–10). First dimen-
sional separation was performed using 700 V for 16 hours,
and then 1000 V for 2 hours at room temperature. Second
dimensional separation was accomplished using an 18
18 cm gel containing an acrylamide gradient of 11.4 to
14 g/dl. Samples were run in 20 gel batches. After
separation, the protein spots were visualized by a photo-
chemical silver -based staining technique.
Detection and Quantification
Following 2D separation, each gel was scanned using a
Kodak CCD camera. A 10241024 pixel format was used,
Table 1. Clinical –Pathological Characteristics of 93 Lung Adenocarcinoma
Patients.
Variable n
Age
<65 49
>65 44
Gender
Female 53
Male 40
Race
White 76
Nonwhite (Asian, Black ) 8
Unknown 9
Smoking
Nonsmoking 10
Smoking 79
Unknown 4
Stage
I 64
III 29
T status
T1 49
T2 – 4 44
N status
N0 68
N1– 2 25
Classification
Bronchoalveolar 14
Bronchial - derived 76
Mixed 3
Differentiation
Well 22
Moderate 47
Poor 23
Lymphocytic response
Yes 41
No 52
Angiolymphatic invasion
Yes 16
No 77
Tumor location
Left lobe 31
Right lobe 62
p53 nuclear accumulation
Positive 19
Negative 69
K- ras mutational status
Positive 34
Negative 40
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yielding pixel widths of 163 m where each pixel had 256
possible gray scale values (optical density ). Spot detection
was accomplished by Bio Image Visage System software
(Bioimage, Ann Arbor, MI). Each gel generated 1600 to 2200
detectable spots, with 820 well -defined spots in most
samples, chosen to obtain quantitative measurements. The
integrated intensity, which is the value of each spot, was
calculated as the measured optical density unitssquare
millimeters. Then spots from each gel were matched to the
820 spots on a ‘‘master’’ gel [11] to allow for the identification
of identical polypeptides between each gel. A total of 250
spots were chosen as ubiquitously expressed reference
spots to allow adjustment for variations in protein loading and
gel staining. Each of the 820 spots was then mathematically
adjusted in relation to the reference spots [12].
MS
Protein spots identified for analysis were extracted from
preparative 2D gels of extracts from A549 lung adenocarci-
noma cell lysates (obtained from ATCC) or lung adenocar-
cinoma tissue lysates (obtained from patient ). The
conditions were identical to the analytical 2D gel, except
there was a 30% greater protein loading, and were silver -
stained by successive incubations in 0.02% sodium thio-
sulfate for 2 minutes, 0.1% silver nitrate for 40 minutes, and
then 0.014% formaldehyde plus 2% sodium carbonate for
10 minutes. Identification of proteins was performed by
trypsin digestion followed by either matrix -assisted laser
desorption ionization time-of - flight mass spectrometry
(MALDI-TOF MS) in the Perseptive Voyager Biospectrom-
etry Workstation (PerSeptive Biosystem, Framingham, MA),
or nanoflow capillary liquid chromatography coupled with
electrospray tandem mass spectrometry (ESI MS/MS) in a
Q-TOF micro (Micromass, Manchester, UK). MALDI-TOF
MS gave a ‘‘fingerprint’’ for each spot based on the molecular
mass of trypsin-digested products and compared the
resulted mass with known trypsin digest databases using
the MSFit database searching (http: //prospector.ucsf.edu/
ucsfhtml3.2/msfit.htm). MS/MS spectra produced by ESI
MS/MS were automatically processed and searched
against a nonredundant database using ProteinLynx Global
SERVER (www. micromass.co.uk).
RNA Isolation for Microarrays
RNAwas isolated from 75 of the tumors and the 10 normal
samples used in the protein studies. Two contiguous 2-mm3
samples were removed for RNA and protein isolation,
respectively. Total cellular RNA was isolated using Trisol
reagent (Life Technologies) and subjected to further
purification using RNeasy columns (Qiagen, Valencia,
CA). Five micrograms of total RNA was used as template.
All protocols used for mRNA reverse transcriptase, second
strand synthesis, production of cDNA and RNA amplification,
hybridization, and washing conditions for the 6800 gene
HUGeneFL oligonucleotide arrays are as provided by the
manufacturer (Affymetrix, Santa Clara, CA). More detailed
information is provided in Giordano et al. [13].
Mutational Analysis of K- ras
Genomic DNA was isolated from each tumor sample and
50 ng was subjected to PCR amplification using the primers
that encompass codons 12 and 13 of the K- ras gene. The
sequences of forward and reverse primers are 50 TATAA-
GGCCTGCTGAAAAT 30 and 50 CCTGCACCAGTAATATGC
30, respectively. Two nanograms of purified PCR products
containing the exon 1 of the K- ras gene was then subjected
to thermal cycle sequencing with an internal nested primer
(50 AGGCCTGCTGAAAATGACT 30 ) and resolved in 8%
urea PAGE gels, dried, and exposed to Phosphor- Image
screens and visualized using a Phosphor- Image scanner
(Molecular Dynamics, Sunnyvale, CA). The mutations were
determined by comparing each tumor DNA sequences of K-
ras 12th and 13th codons to its wild- type sequence
GGTGGC.
Immunohistochemical Staining
Diagnoses for all primary lung adenocarcinomas used in
this study were confirmed by a board-certified pathologist. A
tissue microarray block was assembled based on the best
morphological areas of the tumors used in this study
according to the method of Kononen et al. [14]. Deparaffi-
nized sections of the pulmonary adenocarcinoma tissue
microarray were microwave-pretreated in citric acid to
retrieve antigenicity. The sections were incubated with 1%
hydrogen peroxide for 60 minutes to inhibit endogenous
peroxidase activity at room temperature. Following blocking
to reduce nonspecific binding, the sections were incubated
with primary antibodies overnight at 48C. Antibodies included
anti -p53 (M-7001; 1:500), anti -CK19 (M0772; 1:500), and
anti -CK7 (OV-TL 12/30; 1:500) from DAKO (Carpenteria,
CA); anti -CK7 (K72.7; 1:500; Neomarkers, Fremont, CA);
and anti -CK18 (DC-10; 1:500) and anti -CK8 (TS1; 1:500)
from Novo Castra Laboratories (Newcastle, UK). The
immuno-complex was visualized by the immunoglobulin
enzyme bridge technique using a Vector ABC peroxidase kit
(Vector Laboratories, Burlingame, CA). The enzyme sub-
strate was 3,30 diaminobenzidine tetrachloride, resulting in a
brown reactant. The sections were lightly counterstained
with hematoxylin.
2D Western Blotting
Protein extracts of A549 lung adenocarcinoma cells were
run on 2D gels using the identical conditions as used for the
analytical 2D gels. The separated proteins were transferred
onto polyvinylidene fluoride membranes and incubated for
2 hours at room temperature with a blocking buffer consisting
of TBST (Tris-buffered saline, 0.01% Tween 20) and 5%
nonfat dry milk. Individual membranes were washed and
incubated with monoclonal antibodies listed above for
immunohistochemistry and used at 1:500 dilution. After
additional washes with TBST, the membranes were incu-
bated with a secondary antibody conjugated with horse-
radish peroxidase (HRP) at a 1:5000 dilution for 1 hour,
further washed, and then incubated for 1 minute with
enhanced chemiluminescence (ECL) (Pierce, Rockford, IL).
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Statistical Analysis
A Student’s t - test was used for comparing protein
expression in lung adenocarcinoma versus uninvolved
(normal ) lung. An F - test was used to compare between
values of other clinical–pathological variables by construct-
ing background-adjusted protein spot size quantification.
The transform x!log(1+x ) was applied to all protein
expression measurements. A probability (P ) level <.05
( two-sided) was considered statistically significant. Poten-
tial associations between mRNA and protein expression
were made by calculating Spearman correlation coefficients
for individual genes and gene products within the same
samples.
Survival time was defined as the interval in months
between the day of operation for the lung adenocarcinoma
and the date of lung cancer–related death or last follow-up.
A total of 682 protein spots were included in the survival
analysis after the elimination of spots that were absent from
at least 60% of all the gels. Univariate Cox proportional
hazards regression methods were used to identify proteins
associated with variability in survival times.
Results
CK Isoforms Show Altered Expression in Lung
Adenocarcinoma
Systematic identification of proteins detected in lung
adenocarcinoma tumor and cell lines has uncovered to
date over 300 differentially expressed proteins expressed
in our lung cancer protein database [15]. Four CK types
(CK7, CK8, CK18, and CK19) have been identified
(Figure 1), each of which demonstrated multiple protein
isoforms in tumor samples (Table 2). All four CKs had at
least one or more isoforms that showed significant
increases (P<.05) in lung adenocarcinomas compared to
normal lung. For CK19, two isoforms were overexpressed
Figure 1. 2D PAGE gel image of a stage I lung adenocarcinoma with proteins
separated by molecular mass and isoelectric point. (A ) Location of CK8 spots.
(B ) Location of CK7 spots. (C ) Location of CK18 spots. (D ) Location of CK19
spots.
Table 2. CK Expression in Lung Adenocarcinoma and Their Frequency of Expression in Tumor and Normal Lung Samples.
Spot
Number
Protein
Name
Estimated
Molecular
Mass
Estimated
pI
Univariate Cox
Model P Value
Coefficient b Normal
(n=10 )
Mean±SD
Tumor
(n=93 )
Mean±SD
P ( t - test ) Fold Change
(Tumor /Normal )
Tumor
Frequency*
(%)
Normal
Frequencyy
(% )
691 CK7 41.7 4.9 .025 0.406 0.049±0.066 0.231±0.182 < .0001 4.714 58.1 0.0
871 CK7 41.7 4.7 .005 0.659 0.125±0.167 0.159±0.177 .5566 – – –
1968 CK7 41.0 4.6 .014 0.516 0.303±0.104 0.493±0.282 .0002 1.627 39.80 10.00
2091 CK7 40.4 4.6 .029 0.356 0.325±0.355 0.246±0.211 .3227 – – –
2165 CK7 36.7 4.7 .019 0.487 0.136±0.049 0.119±0.099 .3845 – – –
352 CK8 54.3 5.6 .442 – 0.050±0.023 0.070±0.081 .0768 – – –
436 CK8 50.6 5.2 .101 – 0.313±0.168 0.237±0.123 .1939 – – –
439 CK8 50.7 5.4 .033 0.382 0.165±0.080 0.343±0.132 < .0001 2.078 49.5 0.0
441 CK8 49.7 5.2 .681 – 0.048±0.062 0.103±0.057 .0219 2.158 10.8 0.0
443 CK8 53.1 5.5 .481 – 0.029±0.060 0.042±0.066 .5254 – – –
444 CK8 52.7 5.4 .594 – 0.008±0.026 0.039±0.058 .0062 4.796 23.7 10.0
446 CK8 53.1 5.6 .990 – 0.019±0.030 0.103±0.103 < .0001 5.453 50.5 0.0
451 CK8 54.1 5.7 .814 – 0.013±0.028 0.027±0.052 .1783 – – –
523 CK18 45.4 5.1 .393 – 0.126±0.074 0.304±0.191 < .0001 2.413 50.5 0.0
527 CK18 45.3 5.2 .221 – 0.044±0.060 0.103±0.102 .0186 2.331 15.1 0.0
529 CK18 46.0 5.4 .108 – 0.121±0.097 0.388±0.191 < .0001 3.219 60.2 0.0
2324 CK18 46.0 5.2 .642 – 0.000±0.000 0.117±0.168 < .0001 N /A 36.6 0.0
2381 CK18 46.0 5.3 .084 – 0.000±0.000 0.124±0.111 < .0001 N /A 49.5 0.0
609 CK19 43.6 4.7 .724 – 0.057±0.081 0.132±0.133 .0215 2.305 26.9 0.0
1955 CK19 43.6 4.6 .026 0.433 0.010±0.032 0.163±0.142 < .0001 16.171 67.7 10.0
608 CK19 43.7 4.8 .567 – 0.987±0.512 0.512±0.348 .0170 0.519 50.5 20.0
Normal average+2 SD was used as cut - off value for proteins that were overexpressed in tumor samples. Normal average2 SD was used as cut - off value for
proteins that were underexpressed in tumor samples.
( – ) Placed where value is insignificant due to univariate Cox model P value >.05 or t - test P value >.05.
N /A represents a fold change that cannot be expressed due to normal mean value being zero.
*Frequency of expression in tumor samples is percent of samples greater than cut - off value.
yFrequency of expression in normal samples is percent of samples greater than cut - off value.
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and one isoform (no. 608) was underexpressed in lung
adenocarcinoma.
CK Isoforms Associated with Patient Survival and Other
Clinical–Pathologic Variables
Univariate Cox proportional hazards regression analysis
revealed that one CK8, one CK19, and all five CK7 isoforms
identified by MS were significantly associated (P<.05) with
patient survival. Interestingly, the five CK7 isoforms had
estimated molecular mass ranging from 36.7 to 41.7 kDa,
and estimated pIs ranging from 4.6 to 4.9 that are quite
different from the reported native CK7 molecular mass of
51.3 kDa and pI of 5.5. The estimated pI and molecular mass
for CK 8, 18, and 19 isoforms were relatively similar to their
reported standards [3].
Of the 21 CK isoforms examined, only a subset showed a
significant correlation to other clinical–pathological variables
(Table 3). Relationships between these variables may
provide some insight into the role of these CKs in lung
cancer. F - tests showed that some CK isoforms such as CK7
(no. 691), which had a relationship to survival, were
decreased in bronchial -derived tumors and those with a
positive lymphocytic response. None of the other CK7
isoforms showed a relationship to any clinical–pathological
variables. However, three CK8 isoforms showed relation-
ships to differentiation, positive lymphocytic response, or K-
rasmutation status. One CK18 isoform was also increased in
tumors with a positive lymphocytic response, and of the three
CK19 isoforms, one was increased in tumors with p53 and
K- ras mutations, and one was decreased in poorly differ-
entiated tumors.
2D Western Blot Analysis of CKs
We determined the patterns of reactivity of CKs with 2D
Western blot analysis (Figure 2) of the regions of 2D gels
demonstrating the immunoreactivity shown in Figure 1,
boxes A–D. Outlined box B indicated the region from which
the five overexpressed CK7 proteins identified by MS were
located. The CK8 antibody identified at least 15 separate
immunoreactive proteins (Figure 2B ) including the eight
isoforms that were identified by MS (Figure 1, box A ), and for
which quantitative analysis was performed (Figure 2A ). Two
different monoclonal antibodies to CK7 representing two
different clones were examined (Figure 2, C and D ). Both
antibodies detected some isoforms in common as well as
distinct CK7 isoforms. The location of the immunoreactive
CK7 isoforms is very close to the location to the CK8
fragments (Figure 2B ), and three of the isoforms (436, 444,
446) appear to overlap between CK7 and CK8 fragments. All
Table 3. Relationship Between CKs and Different Clinical –Pathological Variables.
Spot
Number
Protein
Name
Expression in
Stage III Samples
(Versus Stage I )
( n=29 vs 64 )
Expression Bronchial -
Derived Samples
(Versus Bronchioloalveolar )
( n=73 vs 14 )
Expression in Poorly
Differentiated Samples
(Versus Well, Moderate )
( n=23 vs 22,47 )
Expression in p53+
(Versus p53 )
( n=19 vs 69 )
Expression in K - ras+
(Versus K - ras )
( n=34 vs 40 )
Expression in Samples
with Presence of
Lymphocytic Response
(n=39 vs 51 )
691 CK7 down (P= .021 ) down (P= .011 )
352 CK8 up (P= .027 )
436 CK8 up (P= .013 ) down (P= .012 )
451 CK8 down (P= .038 )
2381 CK18 up (P= .032 )
608 CK19 up (P= .027 ) up (P= .028 )
609 CK19 down (P= .003 )
Other CK spots that did not significantly change in expression: 871, 1968, 2091, 2165 (CK7 ); 439, 441, 443, 444, 446 (CK8 ); 527, 529, 2324 (CK18 ); 1955
(CK19 ).
Figure 2. (A ) 2D gel digital image of the silver - stained region shown in
Figure 1, Box A, containing eight CK8 spots expressed in a primary lung
adenocarcinoma. (B ) 2D Western blot analysis using anti -CK8 monoclonal
antibody clone TS1 showing the eight isoforms quantified of the approximately
20 that are immunoreactive in A549 cells. The region is shown in Figure 1,
Box A. (C ) 2D Western blot analysis using anti -CK7 monoclonal antibody
clone OV-TL 12 /30. The region is shown in Figure 1, Box A. (D ) 2D Western
blot analysis using anti -CK7 monoclonal antibody clone K72.7. Three of the
spots ( nos. 436, 444, and 446 ) appear to be at very similar location to CK8
spots and are detected with both CK7 antibodies. None of the five CK7
isoforms detected by mass spectrometry reacted with either antibody. The
unnumbered spots, although detected in the A549, were not abundant enough
to be quantified in the lung and tumor samples. The region is shown in Figure 1,
Box A. (E ) 2D Western blot analysis using anti -CK18 monoclonal antibody
clone DC-10. The region is shown in Figure 1, Box C. Five individual isoforms
were quantified. ( F ) 2D Western blot analysis using anti -CK19 monoclonal
antibody clone M0772. The region is shown in Figure 1, Box D. Three CK19
isoforms were quantified.
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other fragments are clearly distinct from each other, although
their location is similar. The redundancy of the immunostain-
ing may be the result of the extensive sequence similarity of
CK7 and CK8 [16,17].
The immunoreactive CK7 proteins have the same pI and
molecular mass predicted from their sequence; however,
neither of the two CK7 antibodies directed against distinct
clones reacted with the five isoforms identified by MS,
suggesting that these smaller CK7 proteins represented
cleavage products that lacked the epitopes recognized by
these monoclonal antibodies. Quantitative values for the
immunoreactive CK7 isoforms could not be obtained from
the silver -stained gels due to low abundance, although these
forms are relatively abundant in the A549 lung cell line. All
five CK7 isoforms were significantly associated with survival
(P<.05), significantly increased in the adenocarcinomas,
and frequently expressed (58.1% vs 39.8%) relative to
normal lung (Table 2). None of the immunoreactive CK7/
CK8 isoforms showed a significant relationship with survival;
however, spot nos. 444 and 446 were significantly increased
in tumors relative to normal lung. In addition, spot no. 436
showed a significant increased expression in stage III
relative to stage I tumors, and significant decreased ex-
pression in tumors showing lymphocytic response.
Five CK18 and three CK19 isoforms were detected using
MS and 2D Western blots (Figure 2, E and F ) and their
protein abundance quantitatively analyzed (Table 2). Unlike
CK7 and CK8, all CK18 and CK19 isoforms demonstrated
similar molecular mass but varied in pI. Interestingly, all five
CK18 isoforms were significantly increased in the adeno-
carcinomas and detected frequently in these tumors relative
to normal lung (15–60%), but an association with survival
was not observed. The isoform nos. 529 and 523 are the
most abundant in both normal lung and lung adenocarcino-
mas. All three CK19 isoforms were significantly increased in
the adenocarcinoma but only one isoform (no. 1955), the
most positively charged isoform, was associated with
survival and demonstrated the greatest differential expres-
sion between normal lung and the adenocarcinomas. This
isoform was significantly associated with the CK19 mRNA
levels, suggesting that the level of transcription in part can
influence its abundance.
CK mRNA Levels and Correlation to Other Genes
Because the same lung adenocarcinomas and non-
neoplastic lung samples that were quantitatively analyzed for
protein expression were examined at the level of mRNA
abundance using oligonucleotide arrays, correlation coef-
ficients between these CK proteins and the levels of their
corresponding mRNA could be determined.
A positive correlation was observed between the CK
protein expression values for two CK7 isoforms (nos. 165
and 2091) and CK7 mRNA levels (Table 4). One CK8
isoform (no. 439), two CK18 isoforms (nos. 523 and 2324),
and one CK19 isoform (no. 1955) were also significantly
associated with mRNA levels of corresponding genes.
Importantly, univariate Cox proportional hazards regression
analysis revealed that CK7, CK8, CK18, and CK19 mRNA
showed a significant relationship to survival and all four were
significantly increased at the mRNA level in the adeno-
carcinomas relative to normal lung (Table 5). Further, corre-
lation analysis showed that the mRNA levels for all four CK
genes were significantly correlated (P<.05) to one another
(Table 6), suggesting that these increases may reflect a
common mechanism. Further analysis of 4966-expressed
genes examined in these samples revealed two genes
encoding liver -specific bHLH-Zip transcription factor and
smooth and nonmuscle myosin light chain polypeptide to be
significantly correlated to all four CKs.
Cellular Localization of Candidate Proteins
Utilizing the same antibodies used for 2D Western blot
analysis (Figure 2), the expression of the four CK forms was
confirmed as present specifically in lung adenocarcinoma by
immunohistochemistry of tumor tissue arrays (Figure 3).
Table 4. Correlation Coefficients Between CK Protein and mRNA Values.
Spot Number Gene Name Correlation Coefficient ( r )*
2165 CK7 0.35
2091 CK7 0.29
1968 CK7 0.14
691 CK7 0.10
871 CK7 0.18
439 CK8 0.30
441 CK8 0.18
436 CK8 0.11
443 CK8 0.09
352 CK8 0.04
446 CK8 0.03
451 CK8 0.01
444 CK8 0.13
523 CK18 0.33
2324 CK18 0.26
2381 CK18 0.20
529 CK18 0.13
527 CK18 0.04
1955 CK19 0.39
609 CK19 0.15
608 CK19 0.04
*P< .05 if r >0.25.
Table 5. CK mRNA Expression.
Gene Name P (Cox Model ) b Coefficient Normal Mean (n=10 ) Tumor Mean (n=86 ) Fold Change (Tumor /Normal ) P ( t - test )
CK7 .0004 0.0003 951 2146 2.26 < .0001
CK8 .0934 0.0001 1368 3436 2.51 < .0001
CK18 .0006 0.0003 1310 3826 2.92 < .0001
CK19 .0009 0.0003 952 2522 2.65 < .0001
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These arrays contained the same tumors examined in this
study at both the protein and mRNA levels. A very similar
pattern and cytoplasmic localization of all four of these CK
proteins were observed in the lung adenocarcinomas, with
much lower levels detected in normal lung. Interestingly, all
four CKs showed relatively abundant expression in the
epithelial counterpart of the fetal lung, consistent with
previous studies [18].
Discussion
The expression of CKs 7, 8, 18, and 19 in lung adenocarci-
noma includes multiple isoforms for each type and suggests
that regulation may occur at a number of different levels.
Several mechanisms for the regulation of CKs have been
proposed. These intermediate filaments appear to be
assembled and disassembled through rapid phosphorylation
and dephosphorylation reactions on specific serine and
threonine residues [19,20]. Phosphorylation of CKs induced
by cyclic AMP stimulation [21] can be accelerated by
phosphatase inhibition, and can result in the disappearance
of the intermediate filament cytoskeleton [22]. Caspase-
mediated cleavage leading to cytoskeleton disassembly,
formation of pleomorphic cytoplasmic inclusions, and stable
CK fragments [23,24] has been reported. This early
apoptosis- related process has been shown to expose a
neoepitope of CK18 that is not detectable in nonapoptotic
epithelial cells [25].
Bergqvist et al. [5 ] have reported an increase in both CK8
and CK18 in the serum of non small cell lung cancer patients.
The authors attributed this to increased tumor cell turnover
resulting in an increased level of these CK fragments in the
circulation. Alberti et al. [26] also reported massive
fragmentation of CKs induced by calcium-dependent pro-
teases. This rearrangement of CKs has been hypothesized
to play a direct role in carcinogenesis by triggering the
reorganization of chromatin [27], and providing a growth
advantage to the transformed cell. Increased vasculariza-
tion, a characteristic of growing tumors, and the altered
permeability of these new blood vessels were suggested as
responsible for the increase in CK fragments in the serum. It
has been also postulated that endogenously produced
cytokines may lead to reconstruction of the cytoskeleton in
epithelial cells, thus increasing the CKs [5]. Increased CK8
expression was reported in breast carcinoma cell lines,
where it functions as a plasminogen receptor, activating
plasmin, which is important for tumor invasion and cellular
migration [28]. CK8 was reported to contain antigenic
epitopes for antigen CA19-9 [7], which serves as a ligand
for endothelial cell leukocyte molecule-1 (ELAM-1). ELAM-
1 mediates cell–cell interactions between platelets and
endothelial cells with neutrophils, monocytes, and cancer
cells [29,30]. These studies suggest that increased expres-
sion of the CKs may reflect changes in the organization of
cellular architecture during tumor development and progres-
sion. It is likely that the variable expression of the specific CK
isoforms examined in this study also reflects the regulatory
and apoptotic events occurring in lung adenocarcinomas.
Importantly, we not only observed a relationship among
the mRNA overexpression of the four CKs examined in this
study (CKs 7, 8, 18, and 19) and patient outcome in the lung
adenocarcinomas, but also significant overexpression of
many specific isoforms for these proteins. For example, all
five isoforms of CK7 were associated with patient survival.
CK7 has an apparent molecular mass range of 49 to 54.3
Figure 3. (A ) Immunohistochemical analysis of CK18 expression in normal
non -neoplastic lung parenchymal tissue. Staining of individual epithelial cells
is observed but not stromal inflammatory or supporting cell elements. Normal
bronchiole epithelium also demonstrated expression of CK18 (not shown ).
Original magnification, 400. (B ) Immunohistochemical analysis of CK18
expression in a lung adenocarcinoma showing abundant cytoplasmic and
membrane staining in all tumor cells ( arrow ) but not stromal cells. Original
magnification, 400.
Table 6. Correlation Coefficients between CKs and Other mRNA.
Gene Name Correlation Coefficient ( r )*
CK7 CK8 CK18 CK19
CK7 1.00 0.53 0.62 0.43
CK8 – 1.00 0.75 0.52
CK18 – – 1.00 0.40
CK19 – – – 1.00
LISCH7 0.41 0.52 0.43 0.40
MYL6 0.43 0.61 0.41 0.44
*P< .05 if r >0.25.
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kDa and a pI range of 5.2 to 5.5, yet all five forms identified by
MS were smaller and not detected by 2D Western blot
analysis using two different anti -CK7 antibodies. These
results suggest that these smaller CK7 fragments may be
missing the epitopes recognized by the CK7 antibodies and
may represent proteolyically modified forms. Given the
potential importance of these smaller CK7 isoforms by their
strong association with patient survival, determining their
structure and possibly directing antibody production against
these specific isoforms may be very clinically useful.
Eight CK8 of nearly 15 isoforms were quantified and four
found to be significantly overexpressed in lung adenocarci-
nomas. One isoform (no. 439) was associated with an
unfavorable prognosis and was correlated with CK8 mRNA
levels, suggesting that the abundance of this isoform may be
regulated at the level of transcription. Comparison of the
immunoreactive proteins between CK7 and CK8 revealed a
very similar pattern of fragments with three fragments
appearing to overlap. This result is not unexpected given
the extensive protein sequence similarity between both CKs
[16,17]; however, our computer-based matching analyses
reveal many of the isoforms to be unique in their molecular
mass and pI values, suggesting that modifications may differ.
Further, the antibodies utilized for Western blots reportedly
do not cross-react.
All five CK18 isoforms are overexpressed in lung
adenocarcinoma but the native form (529) had the highest
frequency of expression. Given the similar molecular mass
but differing pI of the CK18 isoforms, modification by
phosphorylation may underlie these different charged iso-
forms. The isoforms (nos. 523 and 2324) were significantly
correlated with CK18 mRNA, also suggesting that their
abundance may relate to transcriptional regulation.
CK19 demonstrated three isoforms of similar molecular
mass yet different pIs indicative of potential modification by
phosphorylation. CK19 has been documented as a useful
tumor marker in lung cancer [31,32]. The most abundant
CK19 isoform in both normal and neoplastic lung was no.
608, which was significantly decreased in lung adenocarci-
nomas. The two acidic (nos. 609 and 1955), and potentially
phosphorylated, isoforms were significantly overexpressed
in the adenocarcinomas. Interestingly, the most phosphory-
lated isoform (no. 1955) was highly elevated (16- fold) in the
lung tumors and was associated with unfavorable prognosis.
Correlation analysis of CK mRNA expression revealed a
significant association to the expression of all four CKs to
one another. This suggests that the mechanisms underlying
the increased expression of these proteins in lung tumors
may be similar, possibly reflecting the events associated with
adenocarcinoma development and progression. Of interest,
correlation analysis also revealed two other genes that also
were significantly correlated in their expression to all four CK
genes. This included liver -specific bHLH-Zip transcription
factor and smooth, and nonmuscle, myosin light polypeptide
6 genes. The potential for these genes to be involved in CK
regulation is to be determined, but may provide an approach
to determine whether a common pathway is involved in the
regulation of these proteins.
Acknowledgements
The authors acknowledge the contributions from Lin Lin,
Charles Miller, Melissa Krause, David Wood, Robert Hin-
derer, Rork Kuick, and Eric Puravs.
References
[1] Landis SH, Murray T, Bolden S, and Wingo PA (1999). Cancer
statistics. CA Cancer J Clin 49, 6 –7.
[2] Fry WA, Phillips JL, and Menck HR (1999). Ten - year survey of lung
cancer treatment and survival in hospitals in the United States: a
national cancer data base report. Cancer 86, 1867–76.
[3] Moll R, Franke WW, and Schiller DL (1982). The catalog of human
cytokeratins: patterns of expression in normal epithelia, tumors and
cultured cells. Cell 31, 11–24.
[4] Stigbrand T (2001). The versatility of cytokeratins as tumor markers.
Tumour Biol 22, 1–3.
[5] Bergqvist M, Brattstrom D, Hesselius P, Wiklund B, Silen A, Wagenus
G, and Brodin O. Cytokeratin 8 and 18 fragments measured in serum
and their relation to survival in patients with non - small cell lung cancer.
Anticancer Res 19, 1833–36.
[6] Fernandez -Madrid F, VandeVord PJ, Yang X, Karvonen RL, Simpson
PM, Kraut MJ, Granda JL, and Tomkiel JE (1999). Antinuclear
antibodies as potential markers of lung cancer. Clin Cancer Res 5,
1393–400.
[7] Fujita J, Dobashi N, Ohtsuki Y, Ueda Y, Bandoh S, Yamadori I, and
Takahara J (1999). Detection of large molecular weight cytokeratin 8 as
carrier protein of CA19 -9 in non - small - cell lung cancer cell lines. Br J
Cancer 81, 769–73.
[8] Nagai T, Murota M, Nishioka M, Fujita J, Ohtsuki Y, Dohmoto K, Hojo S,
Dobashi N, and Takara J (2001). Elevation of cytokeratin 19 fragment in
serum in patients with hepatoma: its clinical significance. Eur J
Gastroenterol Hepatol 13, 157–61.
[9] Wells MJ, Hatton MW, Hewlett B, Podor TJ, Sheffield WP, and
Blajchman MA (1997). Cytokeratin 18 is expressed on the hepatocyte
plasma membrane surface and interacts with thrombin–antithrombin
complexes. J Biol Chem 272, 28574–81.
[10] Colby TV, Koss MN, and Travis WD (1995). AFIP Atlas of Tumor
Pathology: Tumors of the Lower Respiratory Tract. Armed Forces
Institute of Pathology, Washington, DC.
[11] Kuick RD, Skolnick MM, Hanash SM, and Neel JV (1991). A two -
dimensional electrophoresis - related laboratory information processing
system: spot matching. Electrophoresis 12, 736–46.
[12] Kuick RD, Hanash SM, Chu EHY, and Strahler JR (1987). A
comparison of some adjustment techniques for use with quantita-
tive spot data from two -dimensional gels. Electrophoresis 8, 199–
204.
[13] Giordano TJ, Shedden KA, Schwartz DR, Kuick R, Taylor JMG, Lee
N, Misek DE, Greenson JK, Kardia SLR, Beer DG, Rennert G, Cho
KR, Gruber SB, Fearon ER, and Hanash S (2001). Organ -specific
molecular classification of primary lung, colon, and ovarian adeno-
carcinomas using gene expression profiles. Am J Pathol 159, 1231–
38.
[14] Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton
S, Torhorst J, Mihatsch MJ, Sauter G, and Kallioniemi OP (1998).
Tissue microarrays for high - throughput molecular profiling of tumor
specimens. Nat Med 4, 844–47.
[15] Oh JMC, Brichory F, Puravs E, Kuick R, Wood C, Rouillard JM, Tra J,
Kardia S, Beer D, and Hanash S (2001). A database of protein
expression in lung cancer. Proteomics 1, 1303–19.
[16] Glass C, and Fuchs E (1988). Isolation, sequence, and differential
expression of a human K7 gene in simple epithelial cells. J Cell Biol
107, 1337–50.
[17] Leube RE, Bosch FX, Romano V, Zimbelmann R, Hofler H, and Franke
WW (1986). Cytokeratin expression in simple epithelia: III. Detection of
mRNAs encoding human cytokeratins nos. 8 and 18 in normal and
tumor cells by hybridization with cDNA sequences in vitro and in situ.
Differentiation 33, 69–85.
[18] Broers JL, de Leij L, Rot MK, ter Haar A, Lane EB, Leigh IM, Wagnaar
SS, Vooijs GP, and Ramaekers FC (1989). Expression of intermediate
filament proteins in fetal and adult human lung tissues. Differentiation
40, 119–28.
[19] Nakamura Y, Takeda M, and Nishimura T (1996). Dynamics of bovine
glial fibrillary acidic protein phosphorylation. Neurosci Lett 205, 91–94.
Neoplasia . Vol. 4, No. 5, 2002
Structural Proteins Over-Expressed in Lung Adenocarcinoma Gharib et al. 447
[20] Giasson BI, and Mushynski WE (1998). Intermediate filament disas-
sembly in cultured dorsal root ganglion neurons is associated with
amino - terminal head domain phosphorylation of specific subunits.
J Neurochem 70, 1869–75.
[21] Escribano J, and Rozengurt E (1988). Cyclic AMP increasing agents
rapidly stimulate vimentin phosphorylation in quiescent cultures of
Swiss 3T3 cells. J Cell Physiol 137, 223–34.
[22] Eriksson JE, Brautigan DL, Vallee R, Olmsted J, Fujiki H, and
Goldman RD (1992). Cytoskeletal integrity in interphase cells
requires protein phosphatase activity. Proc Natl Acad Sci USA 89,
11093–97.
[23] Ku NO, and Omary MB (1994). Identification of the major physiologic
phosphorylation site of human cytokeratin 18: potential kinases and a
role in filament organization. J Cell Biol 127, 161–71.
[24] MacFarlane M, Merrison W, Dinsdale D, and Cohen GM (2000).
Active caspases and cleaved cytokeratins are sequestered into
cytoplasmic inclusions in TRAIL - induced apoptosis. J Cell Biol 148,
1239–54.
[25] Leers MP, Kolgen W, Bjorklund P, Ramaekers FC, Bjorklund B, Nap M,
Jornvall H, and Schutte B (1999). Immunocytochemical detection and
mapping of a cytokeratin 18 neo -epitope exposed during early
apoptosis. J Pathol 187, 567–72.
[26] Alberti I, Barboro P, Barbesino M, Sanna P, Pisciotta L, Parodi S,
Nicolo G, Boccardo F, Galli S, Patrone E, and Balbi C (2000). Changes
in the expression of cytokeratins and nuclear matrix proteins are
correlated with the level of differentiation in human prostate cancer.
J Cell Biochem 79, 471–85.
[27] Spencer AV, Coutts AS, Samuel AK, Murphy LC, and Davie JR (1998).
Estrogen regulates the association of intermediate filament proteins
with nuclear DNA in human breast cancer cells. J Biol Chem 273,
29093–97.
[28] Hembrough TA, Kralovich KR, Li L, and Gonias SL (1996). Cytokeratin
8 released by breast carcinoma cells in vitro binds plasminogen and
tissue - type plasminogen activator and promotes plasminogen activa-
tion. Biochem J 317, 763–69.
[29] Takada A, Ohmori K, Takahashi N, Tsuyuoka K, Yago A, Zenita K,
Hasegawa A, and Kannagi R (1991). Adhesion of human cancer cells to
vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis
A. Biochem Biophys Res Commun 179, 713–19.
[30] Takada A, Ohmori K, Yoneda T, Tsuyuoka K, Hasegawa A, Kiso M, and
Kannagi R (1993). Contribution of carbohydrate antigens sialyl Lewis A
and sialyl Lewis X to adhesion of human cancer cells to vascular
endothelium. Cancer Res 53, 354–61.
[31] Pujol JL, Grenier J, Daures JP, Daver A, Pujol H, and Michel FB (1993).
Serum fragment of cytokeratin subunit 19 measured by CYFRA 21 -1
immunoradiometric assay as a marker of lung cancer. Cancer Res 53,
61–66.
[32] Pujol JL, Gernier J, Parrat E, Lehmann M, Lafontaine T, and Quanyin X
(1996). Cytokeratins as serum markers in lung cancer: a comparison of
CYFRA-21 -1 and TPS. Am J Respir Crit Care Med 154, 725–33.
448 Structural Proteins Over-Expressed in Lung Adenocarcinoma Gharib et al.
Neoplasia . Vol. 4, No. 5, 2002
